vs
Side-by-side financial comparison of Gaming & Leisure Properties, Inc. (GLPI) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
Gaming & Leisure Properties, Inc. is the larger business by last-quarter revenue ($420.0M vs $339.0M, roughly 1.2× HAEMONETICS CORP). Gaming & Leisure Properties, Inc. runs the higher net margin — 57.0% vs 13.2%, a 43.8% gap on every dollar of revenue. On growth, Gaming & Leisure Properties, Inc. posted the faster year-over-year revenue change (6.3% vs -2.7%). Over the past eight quarters, Gaming & Leisure Properties, Inc.'s revenue compounded faster (5.0% CAGR vs 0.4%).
Gaming and Leisure Properties, Inc. is a real estate investment trust (REIT) specializing in casino properties, based in Wyomissing, Pennsylvania. It was formed in November 2013 as a corporate spin-off from Penn National Gaming. The company owns 62 casino properties, all of which are leased to other companies.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
GLPI vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $420.0M | $339.0M |
| Net Profit | $239.4M | $44.7M |
| Gross Margin | — | 59.7% |
| Operating Margin | 79.4% | 19.9% |
| Net Margin | 57.0% | 13.2% |
| Revenue YoY | 6.3% | -2.7% |
| Net Profit YoY | 40.5% | 19.3% |
| EPS (diluted) | — | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $420.0M | — | ||
| Q4 25 | $407.0M | $339.0M | ||
| Q3 25 | $397.6M | $327.3M | ||
| Q2 25 | $394.9M | $321.4M | ||
| Q1 25 | $395.2M | $330.6M | ||
| Q4 24 | $389.6M | $348.5M | ||
| Q3 24 | $385.3M | $345.5M | ||
| Q2 24 | $380.6M | $336.2M |
| Q1 26 | $239.4M | — | ||
| Q4 25 | $275.4M | $44.7M | ||
| Q3 25 | $241.2M | $38.7M | ||
| Q2 25 | $151.4M | $34.0M | ||
| Q1 25 | $165.2M | $58.0M | ||
| Q4 24 | $223.6M | $37.5M | ||
| Q3 24 | $184.7M | $33.8M | ||
| Q2 24 | $208.3M | $38.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | 79.4% | — | ||
| Q4 25 | 89.3% | 19.9% | ||
| Q3 25 | 84.8% | 17.9% | ||
| Q2 25 | 61.3% | 16.8% | ||
| Q1 25 | 65.5% | 21.6% | ||
| Q4 24 | 79.1% | 16.9% | ||
| Q3 24 | 70.4% | 15.0% | ||
| Q2 24 | 77.1% | 11.8% |
| Q1 26 | 57.0% | — | ||
| Q4 25 | 67.6% | 13.2% | ||
| Q3 25 | 60.7% | 11.8% | ||
| Q2 25 | 38.4% | 10.6% | ||
| Q1 25 | 41.8% | 17.5% | ||
| Q4 24 | 57.4% | 10.8% | ||
| Q3 24 | 47.9% | 9.8% | ||
| Q2 24 | 54.7% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.96 | $0.95 | ||
| Q3 25 | $0.85 | $0.81 | ||
| Q2 25 | $0.54 | $0.70 | ||
| Q1 25 | $0.60 | $1.17 | ||
| Q4 24 | $0.79 | $0.74 | ||
| Q3 24 | $0.67 | $0.66 | ||
| Q2 24 | $0.77 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.5M | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $5.0B | $911.5M |
| Total Assets | $13.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $274.5M | — | ||
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | $560.8M | $320.8M | ||
| Q3 24 | $560.8M | $299.3M | ||
| Q2 24 | $560.8M | $344.4M |
| Q1 26 | — | — | ||
| Q4 25 | $7.2B | $1.2B | ||
| Q3 25 | $7.2B | $1.2B | ||
| Q2 25 | $6.9B | $1.2B | ||
| Q1 25 | $6.9B | $1.2B | ||
| Q4 24 | $7.7B | — | ||
| Q3 24 | $7.4B | — | ||
| Q2 24 | $6.6B | — |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $4.6B | $911.5M | ||
| Q3 25 | $4.6B | $849.2M | ||
| Q2 25 | $4.6B | $882.3M | ||
| Q1 25 | $4.2B | $820.8M | ||
| Q4 24 | $4.3B | $906.9M | ||
| Q3 24 | $4.3B | $878.9M | ||
| Q2 24 | $4.1B | $905.4M |
| Q1 26 | $13.8B | — | ||
| Q4 25 | $12.9B | $2.5B | ||
| Q3 25 | $12.8B | $2.4B | ||
| Q2 25 | $12.5B | $2.5B | ||
| Q1 25 | $12.1B | $2.5B | ||
| Q4 24 | $13.1B | $2.5B | ||
| Q3 24 | $12.7B | $2.5B | ||
| Q2 24 | $11.8B | $2.5B |
| Q1 26 | — | — | ||
| Q4 25 | 1.56× | 1.34× | ||
| Q3 25 | 1.57× | 1.44× | ||
| Q2 25 | 1.51× | 1.39× | ||
| Q1 25 | 1.63× | 1.49× | ||
| Q4 24 | 1.81× | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 1.60× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $93.6M | ||
| Q3 25 | $240.3M | $111.3M | ||
| Q2 25 | $293.4M | $17.4M | ||
| Q1 25 | $252.5M | $116.6M | ||
| Q4 24 | $1.1B | $43.8M | ||
| Q3 24 | $270.4M | $48.8M | ||
| Q2 24 | $252.1M | $-27.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $87.2M | ||
| Q3 25 | $183.0M | $106.3M | ||
| Q2 25 | $272.3M | $13.6M | ||
| Q1 25 | $239.6M | $100.9M | ||
| Q4 24 | $1.1B | $35.2M | ||
| Q3 24 | $261.5M | $39.4M | ||
| Q2 24 | $245.0M | $-33.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | 46.0% | 32.5% | ||
| Q2 25 | 69.0% | 4.2% | ||
| Q1 25 | 60.6% | 30.5% | ||
| Q4 24 | 275.3% | 10.1% | ||
| Q3 24 | 67.9% | 11.4% | ||
| Q2 24 | 64.4% | -9.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | 14.4% | 1.5% | ||
| Q2 25 | 5.3% | 1.2% | ||
| Q1 25 | 3.3% | 4.7% | ||
| Q4 24 | 0.0% | 2.5% | ||
| Q3 24 | 2.3% | 2.7% | ||
| Q2 24 | 1.9% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.10× | 2.09× | ||
| Q3 25 | 1.00× | 2.88× | ||
| Q2 25 | 1.94× | 0.51× | ||
| Q1 25 | 1.53× | 2.01× | ||
| Q4 24 | 4.80× | 1.17× | ||
| Q3 24 | 1.46× | 1.44× | ||
| Q2 24 | 1.21× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLPI
Segment breakdown not available.
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
